BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6153836)

  • 21. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
    Cummings J; Matheson LM; Smyth JF
    J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-S-cysteinyldopa and trichochromes in red feathers.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):269-70. PubMed ID: 78644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
    Morishima T; Saito M; Hanawa S
    J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
    [No Abstract]   [Full Text] [Related]  

  • 28. On the occurrence of cysteinyldopa and dopa in melanocytes and benign nevi cells.
    Falck B; Jacobsson S; Lindvall O; Nietsche UB
    Scand J Plast Reconstr Surg; 1976; 10(3):185-8. PubMed ID: 1053447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection.
    Hansson C; Agrup G; Rorsman H; Rosengren AM; Rosengren E; Edholm LE
    J Chromatogr; 1979 Jan; 162(1):7-22. PubMed ID: 33194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Morishima T; Hanawa S
    Acta Derm Venereol; 1981; 61(2):149-50. PubMed ID: 6165192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adrenaline, noradrenaline, dopamine and DOPA in the blood and other tissues of white rats following cranio-cerebral injury].
    Matlina ESh; Rakhmanova TB
    Biull Eksp Biol Med; 1967 Mar; 63(3):55-7. PubMed ID: 5622344
    [No Abstract]   [Full Text] [Related]  

  • 32. Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(4):355-6. PubMed ID: 92151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of cysteinyldopa from glutathionedopa in melanoma.
    Agrup G; Falck B; Kennedy BM; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):1-3. PubMed ID: 46665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Ito S; Kato T; Fujita K
    Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion of 5-S-cysteinyldopa in the urine of healthy subjects.
    Agrup G; Falck B; Fyge K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):7-9. PubMed ID: 46677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive high-performance liquid chromatographic method for the determination of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
    Fornstedt-Wallin B; Bergh I
    J Chromatogr B Biomed Appl; 1995 Jan; 663(1):9-14. PubMed ID: 7704217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.
    Fornstedt B; Carlsson A
    J Neural Transm; 1989; 76(2):155-61. PubMed ID: 2496196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of aminazin on the content of adrenaline, nordrenaline, dopamine and dopa in rat tissue in closed cranio-cerebral trauma].
    Matlina ESh; Rakhmanova TB
    Farmakol Toksikol; 1969; 32(2):138-40. PubMed ID: 5772133
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-S-cysteinyldopa and pigment response to UVA light.
    Tegner E; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):21-5. PubMed ID: 6191484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
    Fornstedt B; Rosengren E; Carlsson A
    Neuropharmacology; 1986 Apr; 25(4):451-4. PubMed ID: 3086766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.